Clinical Trial Update: Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of sorafenib and 5-azacitidine in patients with acute myeloid leukemia and myelodysplastic syndromes; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Nexavar (Sorafenib)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-05-06